Guggenheim Capital’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-4,779
Closed -$234K 2839
2016
Q4
$234K Sell
4,779
-465
-9% -$21.5K ﹤0.01% 2660
2016
Q3
$251K Sell
5,244
-186
-3% -$9.19K ﹤0.01% 2603
2016
Q2
$291K Buy
5,430
+141
+3% +$6.64K ﹤0.01% 2552
2016
Q1
$237K Buy
+5,289
New +$215K ﹤0.01% 2635
2015
Q4
Sell
-53,201
Closed -$1.69M 2987
2015
Q3
$1.69M Buy
53,201
+539
+1% +$18.8K 0.01% 1722
2015
Q2
$1.74M Buy
52,662
+13,411
+34% +$478K ﹤0.01% 1873
2015
Q1
$1.61M Buy
39,251
+8,069
+26% +$326K ﹤0.01% 1953
2014
Q4
$1.27M Sell
31,182
-2,057
-6% -$80.4K ﹤0.01% 2069
2014
Q3
$1.22M Sell
33,239
-7,223
-18% -$312K ﹤0.01% 2109
2014
Q2
$1.87M Sell
40,462
-5,083
-11% -$226K ﹤0.01% 1878
2014
Q1
$1.87M Sell
45,545
-14,990
-25% -$557K 0.01% 1841
2013
Q4
$2.31M Buy
+60,535
New +$1.87M 0.01% 1650

Other funds holding ANIK